|
|
The roles of biomarkers
in preeclampsia management
Date: 28 June 2019
Time: 14:00–15:00 (GMT+8)
|
|
|
Dear Doctor,
Angiogenic biomarkers have recently been shown to improve the clinical management of preeclampsia.
Preeclampsia is a placental disease caused by trophoblast dysfunction. The angiogenic factors placental growth factor (PlGF) and soluble fms-like tyrosine kinase 1 (sFlt-1), all originating at least in part from the trophoblast, are biomarkers with predictive potential for preeclampsia and related adverse outcomes.
Join the webinar to learn more on angiogenic biomarkers in preeclampsia on Friday 28 June 2019 at 14:00 (GMT+08:00).
|
|
Topics:
 |
The Roles of Biomarkers in Preeclampsia Management |
 |
How to implement biomarkers in routine preeclampsia management |
Why should you attend?
 |
Biomarkers in Preeclampsia Management and practical experience |
 |
Live Q&A sessions with the speakers |
 |
Women’s Health updates after the webinar |
|
|
|
|
|
| |
Speaker
Prof Manu Vatish
MBBCh BA(Hons) DPhil MA(Cantab) MRCOG
Nuffield Department of Obstetrics and Gynaecology
Oxford University, United Kingdom
|
|
| |
Moderator
Prof Gao Jin Song
Chief Physician, Professor and Deputy Director
Department of Obstetrics and Gynaecology
Peking Union Medical College Hospital,
Chinese Academy of Medical Sciences
|
|
| |
|
|
|
|
|
| Live Webinar Date & Time |
 |
Date: |
|
28 June 2019 |
|
| |
Can't make it?
Register now to view the recording after the live webinar.
|
|
|
|
 |
Time: |
|
|
14:00–15:00 |
(GMT+08:00) |
|
11:00–12:00 |
(Karachi) |
|
11:30–12:30 |
(Delhi) |
|
13:00–14:00 |
(Bangkok / Ho Chi Minh / Jakarta) |
|
14:00–15:00 |
(Hong Kong / Kuala Lumpur / Singapore) |
|
15:00–16:00 |
(Seoul / Tokyo) |
|
16:00-17:00 |
(Melbourne) |
|
|
Can't make it?
Register now to view the recording after the live webinar.
|
|
|
|
|
|
|
|
